Methylprednisolone for idiopathic granulomatous mastitis: a prospective observational cohort study

ABSTRACT:

Background

Idiopathic granulomatous mastitis (IGM) is a rare, benign, but locally aggressive breast disease. Steroids are widely used as a breast-conserving option, however, the response rate of steroids varies in reported studies, as well as its different reported usage. This prospective observational cohort study aimed to report the outcomes of methylprednisolone for IGM treatment.

Methods

From Aug 2019 to Dec 2021, the clinicopathological information of 156 IGM patients who sought treatment at West China Hospital was prospectively collected. A total of 88 patients treated with methylprednisolone were included in the study. The clinical features, treatment response, and follow-up data were analyzed.

Results

The median age at diagnosis was 32 years, and 90.9% of

SUBMITTER: Tan Q 

PROVIDER: S-EPMC9547707 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature